Table 1.
Characteristics of the forty older participants assessed.
| Elderly activity group |
||
|---|---|---|
| Most active (MA) | Least active (LA) | |
| Gender (M/F) | 10/10 | 10/10 |
| Age (years) | 67.4 ± 5.0 | 66.6 ± 4.9 |
| Physical Activity | ||
| Steps (per day) | 10370 ± 3221 | 4746 ± 1351∗∗∗ |
| IPAQ (AU) | 29.4 ± 16.9 | 13.4 ± 11.3∗ |
| Physical Functioning | ||
| Grip Strength (kg) | 30 ± 9 | 32 ± 9 |
| Berg Balance Score (AU) | 55.2 ± 1.4 | 55.3 ± 1.1 |
| Timed-up-and-go (seconds) | 8.1 ± 1.5 | 8.4 ± 1.4 |
| Clinical | ||
| BMI (kg/m2) | 23.5 ± 3.1 | 26.7 ± 3.9∗∗ |
| Body Fat (%) | 26.2 ± 7.9 | 31.5 ± 6.7∗ |
| Blood Pressure | ||
| Systolic (mmHg) | 128 ± 16 | 127 ± 13 |
| Diastolic (mmHg) | 77 ± 6 | 77 ± 7 |
| Resting Heart Rate (bpm) | 65 ± 9 | 64 ± 8 |
| Current Smoker (Y/N) | 0/20 | 2/18 |
| Use of Statins (Y/N) | 1/19 | 5/15 |
| Physiological | ||
| White Blood Cells | ||
| Neutrophils (109/L) | 3.08 ± 0.8 | 3.34 ± 0.8 |
| Monocytes (109/L) | 0.27 ± 0.08 | 0.32 ± 0.12 |
| Lymphocytes (109/L) | 1.28 ± 0.28 | 2.00 ± 1.64 |
| Fasting Glucose (mmol/L) | 5.0 ± 0.4 | 5.4 ± 0.5∗ |
| Fasting Insulin (μIU/ml) | 12.3 ± 4.1 | 20.9 ± 11.5∗∗ |
| HOMA-IR (AU) | 2.8 ± 1.1 | 5.1 ± 3.2∗∗ |
| Triglycerides (mmol/L) | 1.14 ± 0.56 | 1.16 ± 0.62 |
| Cholesterol [statin+ (mmol/L)] | 5.80 | 4.15 ± 0.47 |
| Cholesterol [statin− (mmol/L)] | 5.75 ± 0.97 | 5.04 ± 1.34 |
| Leptin (ng/ml) | 9.9 ± 7.8 | 15.7 ± 8.7∗ |
| Adiponectin (μg/ml) | 4.2 ± 2.0 | 3.1 ± 1.1∗ |
| Leptin: Adiponectin Ratio | 2.5 ± 1.9 | 5.5 ± 3.7∗∗ |
IPAQ (International Physical Activity Questionnaire); AU (Arbitrary Units); BMI (Body Mass Index); HOMA-IR (Homeostasis Model Assessment for Insulin Resistance); Statin+ (Prescribed statins); Statin- (Not prescribed statins). Data are mean ± SD unless indicated otherwise. *p < 0.05, **p < 0.01, ***p < 0.001 compared to MA.